Format

Send to

Choose Destination
J Biotechnol. 2016 Mar 10;221:91-100. doi: 10.1016/j.jbiotec.2016.01.032. Epub 2016 Jan 25.

Constitutive production and efficient secretion of soluble full-length streptavidin by an Escherichia coli 'leaky mutant'.

Author information

1
Lehrstuhl für Fermentationstechnik, Technische Fakultät, Universität Bielefeld, PF 10 01 31, D-33501 Bielefeld, Germany. Electronic address: jmu@fermtech.techfak.uni-bielefeld.de.
2
Lehrstuhl für Fermentationstechnik, Technische Fakultät, Universität Bielefeld, PF 10 01 31, D-33501 Bielefeld, Germany.

Abstract

Due to its various applications the protein streptavidin is a highly interesting target for heterologous production. This study focuses on different Escherichia coli-based constructs targeting a high-level expression and secretion of streptavidin to the medium. The effect of various promoters, variants of the target gene, leader sequences and host strains on expression and secretion into the culture broth was analyzed. Constitutive production of full-length streptavidin fused with the leader sequence of the bglA gene from Bacillus amyloliquefaciens by the periplasmic 'leaky mutant' E. coli JW1667-5 (Δlpp-752:kan) at 30°C generated the highest yield of the conditions tested, surpassing the extracellular concentration of a conventional T7-based expression system. Supplementation of the medium by the non-ionic surfactants Triton(®) X-100 and X-45 led to an improved secretion of the protein to the culture supernatant. Tetrameric concentrations of streptavidin of 2790±166nM were reached in shake flasks at a productivity of 49.6nMh(-1). Optimization of conditions led to a successful transfer to the bioreactor, yielding a maximal concentration of 2608±169nM and a productivity of 65.2nMh(-1) in fed-batch operation. The proportion of biotin-blocked binding sites of 8.3±4.3% indicated a highly bioactive product.

KEYWORDS:

Chain length of streptavidin; Escherichia coli; Fed-batch cultivation; Periplasmic leaky mutant; Secretion; Temperature

PMID:
26820322
DOI:
10.1016/j.jbiotec.2016.01.032
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center